Oncologia
Chemioterapia · Immunoterapia · Tumour Board
Oncology treatment in the Balkans combines European medical standards with significantly shorter waiting times. Turkish JCI hospitals run weekly multidisciplinary tumour boards (MDTs), offer access to immunotherapy and targeted therapy trials, and provide dedicated international patient oncology coordinators who communicate in English.
Available in
Turkey
Istanbul, Ankara, Izmir
Bulgaria
EU · Sofia, Plovdiv, Varna
Greece
EU · Athens, Thessaloniki
Procedures & Prices
Oncologia — All Treatments
Prices are indicative ranges. Your exact quote depends on complexity and chosen clinic.
| Procedure | Balkans Price | Save |
|---|---|---|
PET-CT Scan (full body)Popular | €1,000–€2,000 | 57% |
MRI with contrast (organ-specific) | €300–€700 | 62% |
CT Scan with contrast | €200–€500 | 61% |
Tumour Biopsy + Histopathology | €500–€1,500 | 62% |
Molecular / Genetic Tumour Testing (NGS) | €800–€2,500 | 56% |
Tumour Board / MDT Second OpinionPopular | €500–€1,500 | 62% |
By Country
Oncology — Price Comparison
| Procedure | BG Bulgaria | TR Turkey | GR Greece | UK / DE |
|---|---|---|---|---|
| PET-CT Scan | €1,400 Save 60% | €1,200 Save 66% | €1,500 Save 57% | £3,500 |
| IMRT Radiotherapy | €8,000 Save 60% | €7,000 Save 65% | €9,000 Save 55% | £20,000 |
| Robotic Surgery | — | €10,000 Save 60% | €12,000 Save 52% | £25,000 |
Prices are estimates. Get a personalised quote from our partner clinics.
Why Choose the Balkans
Why patients choose Oncologia in the Balkans
Multidisciplinary tumour boards
Weekly MDT meetings (oncologist, surgeon, radiologist, pathologist, radiotherapist) ensure every case is reviewed by the full team — standard in JCI hospitals, often bypassed in rushed private UK settings.
Access without waiting
PET-CT within 48 hours. Oncology consultation within 1 week. No 18-week RTT waits for diagnostics that determine your treatment path.
Latest radiation technology
Partner hospitals use TrueBeam, Varian Halcyon and Elekta Unity MR-Linac — the same equipment used in UK cancer centres.
Dedicated international coordinators
Each patient gets a dedicated English-speaking oncology nurse coordinator who manages logistics, translates reports and liaises between your home team and the Balkan oncologists.
Ready to get your personalised quote?
Free consultation · No commitment · English-speaking coordinator
Frequently Asked Questions
Oncologia Abroad — FAQs
Should I get an oncology second opinion abroad?▾
Yes, second opinions change the treatment plan in 15–30% of cancer cases according to published studies. Getting a second opinion from an independent multidisciplinary team costs €500–1,500 and can be arranged remotely by sending your pathology slides and imaging.
Can I receive chemotherapy abroad and continue in the UK?▾
Yes. Many patients begin a treatment programme in Turkey or Bulgaria for the diagnostic/planning phase, then continue maintenance chemotherapy back home. Your Balkan oncologist provides a detailed protocol report for your UK oncologist.
What is an MDT (multidisciplinary team) meeting?▾
An MDT is a weekly meeting where oncologist, surgeon, radiologist, pathologist and sometimes geneticist review every cancer case collectively. This is the standard of care in UK NHS cancer centres and is replicated at JCI-accredited Balkan hospitals.
Is immunotherapy available in Turkey?▾
Yes — checkpoint inhibitors (pembrolizumab/Keytruda, nivolumab/Opdivo, atezolizumab/Tecentriq) are available in Turkish JCI hospitals. Some hospitals participate in clinical trials offering access to novel agents not yet approved in Europe.
How do I send my pathology slides for a second opinion?▾
Physical slides can be shipped via courier, or many labs now provide digital scanning (WSI) that can be reviewed remotely. BalcanCare coordinates this process — we arrange slide retrieval from your UK pathology lab and secure transfer to the Balkan institution.
What genetic testing is available?▾
NGS (next-generation sequencing) tumour panels covering 300–500 genes are available in Istanbul and Sofia. Results take 10–15 working days and identify actionable mutations (BRCA, KRAS, EGFR, ALK, etc.) that may qualify you for targeted therapies.
Related Treatments